Can We Distinguish Anxiety From Depression?
By David S. Baldwin, FRCPsych, Dwight L. Evans, MD, Robert M. A. Hirschfeld, MD, and Siegfried Kasper, MD
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
By Johan A. den Boer, MD, Dwight L. Evans, MD, Sing Lee, MD, PhD, and Rafael Salin-Pascual, MD
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
By Madhukar Trivedi, MD
Mechanism of Action of Antidepressants
By Francesc Artigas, PhD, David J. Nutt, MD, PhD, and Richard Shelton, MD
Depression in the Elderly
By William M. McDonald, MD, Carl Salzman, MD, and Alan F. Schatzberg, MD
Coping With Somatic Comorbidities: Striving for Complete Recovery
By Christer Allgulander, MD, and Siegfried Kasper, MD
Generalized Anxiety Disorder: Raising the Expectations of Treatment
By Christer Allgulander, MD, and David V. Sheehan, MD, MBA
Long-Term Treatment Strategies in Affective Disorders
By Martin B. Keller, MD
Recent Advances in the Neurobiology of Depression
By Charles B. Nemeroff, MD, PhD
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
Intermittent Fluoxetine Dosing in the Treatment of Women With Premenstrual Dysphoria
By Meir Steiner, MD, PhD, FRCPC, Marilyn Korzekwa, MD, FRCPC, John Lamont, MD, MSc, FRCSC, and Annette Wilkins, BA
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
By Lindsay DeVane, PharmD
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
A Discussion on the Methodologies Used to Evaluate Antidepressants
MODERATOR: Jan A. Fawcett, MD
DISCUSSANTS: Norman Sussman, MD Jeffrey H. Newcorn, MD
Risperidone: Review of Its Therapeutic Utility in Depression
By Joyce E. Myers, MD, and Michael E. Thase, MD
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
By Mikael Landén, MD, PhD, and Michael E. Thase, MD
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
By Kamila S. White, PhD and Susan D. Raffa, MA
Economic Impacts of Anxiety Disorders
By Ernst R. Berndt, PhD and Tamar Sisitsky, MA
Anxiety Disorders
Overview:
Vast Progress but a Long Journey Ahead
By Tracey M. Boudine
Psychiatric Bulletin:
Late-Breaking Clinical News
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
By Steven E. Bruce, PhD and Kamila S. White, PhD
Genetics of Schizophrenia: Recent Advances
By Amy Eisener, BS, Michele T. Pato, MD, Helena Medeiros, MSW, Celia Carvalho, MS, and Carlos N. Pato, MD
Neuropsychiatric Update: Neuroimaging Schizophrenia
By Shawn J. Kile, MD
By Laura B. Dunn, MD
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
MODERATOR: Brian A. Meltzer, MD, MBA
DISCUSSANTS: Leo R. Zacharski, MS, MD, and Steven R. Deitcher, MD
Novel Mechanisms in the Future of Cancer Treatment: Angiogenesis & Signal Transduction
MODERATOR: Michael Goldstein, MD
DISCUSSANTS: Roy S. Herbst, MD, PhD, and Michael S. Gordon, MD